Pfizer: Why Wall Street Habitually Overestimates Target Price

2026-03-27 15:48:02 ET

Pfizer stock: Wall Street loves it again

I last covered Pfizer Inc. stock (NYSE: PFE ) on Feb 19. The article rated the stock as hold after examining its FQ4 earnings report (ER) and dividend declarations. Since then, a few new catalysts have caught my attention and motivated this follow-up. The rest of this article will focus on three of them: the sentiment changes from Wall Street, the new development for the “TrumpRx" and "Most-Favored-Nation" pricing models, and also the updates on its pipeline....

Read the full article on Seeking Alpha

For further details see: